Rallybio (RLYB) Share-based Compensation (2020 - 2026)
Rallybio (RLYB) posted Share-based Compensation of $405,000 for Q3 2026, down 61.3% from $1.05 million a year earlier and down 4.5% from the prior quarter.
Powered by 
Analysis
Rallybio (RLYB) Share-based Compensation (2020 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Share-based Compensation at Rallybio was $2.22 million, down 65.9% year-over-year; for FY2025, it was $5.31 million, down 33.5% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 49.8% (FY2020 to FY2025).
- In prior years, Rallybio's Share-based Compensation was $7.99 million in FY2024 (-26.8%), $10.92 million in FY2023 (+15.0%), $9.5 million in FY2022 (+160.6%) and $3.65 million in FY2021 (+417.8%).
- The Q3 2026 figure stands as the lowest quarterly Share-based Compensation since Q4 2020.
- On a year-over-year basis, Share-based Compensation has declined in each of the last 11 quarters, with an average decline of 45.0% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2021, with growth of 567.7%; the weakest was Q2 2026, with a decline of 73.7%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $424,000 (Q2 2026), $613,000 (Q1 2026) and $774,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Rallybio | 84.05 Mn | -201.02 Mn | - | 405,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 405,000.00 |
| Jun 30, 2026 | 424,000.00 |
| Mar 31, 2026 | 613,000.00 |
| Dec 31, 2025 | 774,000.00 |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.61 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 2.55 Mn |
| Sep 30, 2023 | 2.63 Mn |
| Jun 30, 2023 | 2.69 Mn |
| Mar 31, 2023 | 3.05 Mn |
| Dec 31, 2022 | 2.29 Mn |
| Sep 30, 2022 | 2.50 Mn |
| Jun 30, 2022 | 2.65 Mn |
| Mar 31, 2022 | 2.05 Mn |
| Dec 31, 2021 | 1.53 Mn |
API Access
Rallybio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RLYB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RLYB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RLYB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();